Ahead of ECCMID 2024, catch up on-demand with Cepheid’s 2023 symposium recording, and discover our expert-led 2024 ECCMID programmes.
In 2023, delegates heard from leaders in their respective fields present in-depth research on current and emerging healthcare threats, notably the detection of organisms that might cause future pandemics, antimicrobial resistance, as well as respiratory threats posed by Flu and COVID-19 variants, with contemporary evidence on how fast molecular tests improve patient management, infection control and antimicrobial stewardship. As we look ahead to 2024, listen to the symposium on-demand now.
Save the Date for our ECCMID 2024 Symposiums & Programme
“Innovating rapid molecular diagnostics for infectious diseases: real world impact on patient care”
Sunday, 28th April 2024
13.30-15.30 I Hall N & Online
Chair: Beryl Oppenheim, Senior Director, Cepheid
"Rapid multiplex PCR for respiratory viruses reduces time to result and improves clinical care: results of a systematic review and meta-analysis"
Tristan Clark, Associate Professor and Honorary Consultant in Infectious Diseases
University Hospital Southampton NHS Foundation Trust, UK
"Management of respiratory diseases in the emergency department"
Clemens Kill, Director, Center of Emergency Medicine
Essen University, Germany
"Catching the ESKAPEs: can rapid surveillance impact our control efforts?"
Valeria Cento, Associate Professor of Microbiology
Humanitas Research Hospital, Italy
"Novel approaches to CDI patient management with rapid PCR"
Elena Reigadas, Microbiologist
Hospital Gregorio Marañón, Spain
“Tackling antimicrobial resistance in Europe: prevention through diagnostics as the best defense”
Monday, 29th April 2024
12.15-13.15 I Hall P & Online
Chair: Beryl Oppenheim, Senior Director, Cepheid
"Tackling AMR: Economist Perspective"
Olga Jonas, Economist
Former Advisor World Health Bank, Sr. Fellow Harvard University, France
"Tackling AMR: Policy Maker Perspective"
Andrew Ullmann, MP
Member of German Bundestag, UNITE Network, Germany
"Tackling AMR: Clinician Perspective"
Jose Paiva, Director Intensive Care Medicine Service
Centro Hospitalar Universitário São João, Portugal
"Tackling AMR: Patient Perspective"
Venessa Carter, AMR Patient Survivor and One Health Advocate
The AMR Narrative, UK
Save the Date for our ECCMID 2024 Meet the Expert Sessions
Meet the Expert: Dr. Jan Gorm Lisby
Sunday, 28th April 2024
12.15-13.15 I Cepheid Booth C8
"Considerations regarding evaluation of point of care molecular tests for respiratory viruses"
Dr. Jan Gorm Lisby, Chief Consultant Dept. of Clinical Microbiology
Hvidovre Hospital, Denmark
Meet the Expert: Dr. Fredric Janvier
Monday, 29th April 2024
12.15-13.15 I Cepheid Booth C8
"Carbapenemases screening of high-risk patients with a commercial test: a 4-year follow-up study"
Dr Fredric Janvier, Médecin en Chef (COL)
Professeur agrégé du Val-de-Grâce
Hôpital d’Instruction des Armées Sainte Anne, France
References
CE-IVD. In Vitro Diagnostic Medical Device. May not be available in all countries.
